Christian Munkel
Overview
Explore the profile of Christian Munkel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bar S, Buchholz O, Munkel C, Schlett P, Levan P, von Elverfeldt D, et al.
IEEE Trans Biomed Eng
. 2025 Mar;
PP.
PMID: 40031243
Objective: The Blood-Brain Barrier (BBB) is the gatekeeper of the central nervous system, effectively shielding the brain from blood- borne threats but simultaneously represents a significant challenge for treating neurological...
2.
Buchholz O, Sajjamark K, Franke J, Wei H, Behrends A, Munkel C, et al.
Theranostics
. 2024 Jan;
14(1):324-340.
PMID: 38164157
Theranostic platforms, combining diagnostic and therapeutic approaches within one system, have garnered interest in augmenting invasive surgical, chemical, and ionizing interventions. Magnetic particle imaging (MPI) offers a quite recent alternative...
3.
Joseph K, Kirsch M, Johnston M, Munkel C, Stieglitz T, Haas C, et al.
Biomaterials
. 2021 Nov;
279:121230.
PMID: 34736153
Long term implantation of (micro-)probes into neural tissue causes unique and disruptive responses. In this study, we investigate the transcriptional trajectory of glial cells responding to chronic implantation of 380 ...
4.
Mottaghi S, Kohl S, Biemann D, Liebana S, Montano Crespo R, Buchholz O, et al.
Front Neurosci
. 2021 Aug;
15:700672.
PMID: 34456673
Cortico-basal ganglia beta oscillations (13-30 Hz) are assumed to be involved in motor impairments in Parkinson's Disease (PD), especially in bradykinesia and rigidity. Various studies have utilized the unilateral 6-hydroxydopamine...
5.
Winkler C, Reis J, Hoffmann N, Gellner A, Munkel C, Curado M, et al.
eNeuro
. 2017 Oct;
4(5).
PMID: 28966974
Restorative therapy concepts, such as cell based therapies aim to restitute impaired neurotransmission in neurodegenerative diseases. New strategies to enhance grafted cell survival and integration are still needed to improve...
6.
Missiou A, Rudolf P, Stachon P, Wolf D, Varo N, Aichele P, et al.
Circ Res
. 2010 Jul;
107(6):757-66.
PMID: 20651286
Rationale: Tumor necrosis factor receptor-associated factors (TRAFs) are cytoplasmic adaptor proteins for the TNF/interleukin-1/Toll-like receptor superfamily. Ligands of this family comprise multiple important cytokines such as TNFα, CD40L, and interleukin-1β...
7.
Missiou A, Kostlin N, Varo N, Rudolf P, Aichele P, Ernst S, et al.
Circulation
. 2010 Apr;
121(18):2033-44.
PMID: 20421522
Background: Members of the tumor necrosis factor superfamily, such as tumor necrosis factor-alpha, potently promote atherogenesis in mice and humans. Tumor necrosis factor receptor-associated factors (TRAFs) are cytoplasmic adaptor proteins...
8.
Missiou A, Wolf D, Platzer I, Ernst S, Walter C, Rudolf P, et al.
Thromb Haemost
. 2010 Feb;
103(4):788-96.
PMID: 20174757
CD40L figures prominently in atherogenesis. Recent data demonstrate elevated levels of sCD40L in the serum of patients with the metabolic syndrome (MS). This study investigated the role of CD40L in...